Results were announced from a phase 3 trial evaluating solriamfetol for major depressive disorder with/without severe excessive daytime sleepiness.

CytoSorbents Corporation , a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, announced the extension of the expiration ...

Rice University has launched the Institute of Health Resilience and Innovation (IHRI), a pioneering research initiative dedicated to understanding the lifetime impacts of health stressors and ...

The major indexes suffered their worst weekly losses in years as the latest Trump tariffs were far higher than expected.

Glendo, Wyoming, April 04, 2025 (GLOBE NEWSWIRE) -- Prepare for a television event that redefines the battle for business supremacy! " Total Disruption: Business Battleground ," the groundbreaking ...